Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004680 220015841 null 96.6 Curative (C) 2016-04-18 2017-06-27 AML17 TRIAL N N 220026573 AML17 TRIAL
220004681 220001857 null null Palliative (P) 2017-09-27 2017-09-28 Cytarabine low (10to20mg/m2) IV/SC 2 N 220026576 CYTARABINE
220004682 220001857 1.71 67.8 Curative (C) 2013-08-02 2013-08-03 Trial Unspecified Y N 220026576 TRIAL
220004686 220001860 0 75 Palliative (P) 2016-06-04 2016-06-04 CYTARABINE null null 220026587 CYTARABINE
220004687 220001860 null null Palliative (P) null 2016-06-18 Cytarabine low (10to20mg/m2) IV/SC null null 220026587 CYTARABINE
220004688 220001860 1.69 67.2 Palliative (P) 2016-01-31 2016-02-04 AML17 TRIAL 2 N 220026587 AML17 TRIAL
220004689 220001861 null 68 Disease modification (D) 2014-05-30 2014-06-02 Trial Unspecified 01 N 220026595 TRIAL
220004690 220001861 1.65 58.4 Not known (9) 2014-08-21 2014-08-26 Trial Unspecified Y N 220026595 TRIAL
220004691 220001861 1.7 58 Palliative (P) 2016-07-26 2016-07-27 Cytarabine Low Dose 02 N 220026595 CYTARABINE
220004692 220001861 1.48 58.4 Not known (9) 2016-11-07 2016-11-07 Trial Unspecified Y N 220026595 TRIAL
220004693 220020284 null 86 Palliative (P) 2016-06-19 2016-06-19 Trial Unspecified Y N 220026599 TRIAL
220004694 220020284 null 69 Curative (C) 2016-01-21 2016-01-21 AML17 TRIAL N N 220026599 AML17 TRIAL
220004695 220001862 1.58 null Disease modification (D) null 2015-05-08 Cytarabine Low Dose 2 null 220026603 CYTARABINE
220004696 220010952 1.73 null Not known (9) 2013-08-30 2014-09-01 Cytarabine Low Dose N N 220026604 CYTARABINE
220004697 220010952 1.74 100 Palliative (P) 2013-11-06 2014-05-29 Cytarabine Low Dose N N 220026604 CYTARABINE
220004698 220001863 1.69 0 null 2015-07-27 2015-09-07 Cytarabine Low Dose 02 N 220026608 CYTARABINE
220004699 220010953 1.59 59.4 Curative (C) 2016-02-08 2016-02-14 AML17 TRIAL N N 220026609 AML17 TRIAL
220004700 220001864 0 null Adjuvant (A) 2017-02-20 2017-02-20 CYTARABINE 02 N 220026611 CYTARABINE
220004701 220001864 null 80 null 2014-07-26 2014-09-27 AML17 TRIAL Y N 220026611 AML17 TRIAL
220004702 220001865 0 81.6 null 2013-11-22 2013-11-22 Cytarabine low (10to20mg/m2) IV/SC 02 N 220026613 CYTARABINE
220004703 220001866 1.53 73.2 Curative (C) 2013-08-27 2013-08-27 AML17 TRIAL null N 220026614 AML17 TRIAL
220004704 220001867 0 102 null 2016-04-30 2016-05-07 Trial Unspecified 01 N 220026621 TRIAL
220004705 220001867 null 56.8 null 2013-07-19 2013-07-19 AML17 TRIAL 2 N 220026621 AML17 TRIAL
220004706 220001867 1.87 102.7 Curative (C) 2018-01-01 2018-01-04 AML17 TRIAL Y N 220026621 AML17 TRIAL
220004708 220001869 null 115.4 Curative (C) 2018-01-09 2018-01-23 Trial Unspecified Y N 220026632 TRIAL
220004709 220001870 null 69.4 Curative (C) 2014-08-10 2014-08-10 AML17 TRIAL 1 N 220026634 AML17 TRIAL
220004710 220001870 null 87.7 Palliative (P) 2014-11-04 2014-11-04 Trial Unspecified 01 N 220026634 TRIAL
220004711 220001870 null null Radical (R) 2014-05-08 2014-05-21 Trial Unspecified Y N 220026634 TRIAL
220004712 220001870 1.7 67.55 Palliative (P) 2017-06-02 2017-07-16 Cytarabine Low Dose 2 N 220026634 CYTARABINE
220004713 220001870 1.72 92 Curative (C) 2014-02-14 2014-03-24 AML17 TRIAL Y N 220026634 AML17 TRIAL
220004714 220001871 1.41 70 Palliative (P) 2017-05-07 2017-05-24 CYTARABINE N null 220026642 CYTARABINE
220004715 220001872 1.77 null Curative (C) 2017-01-13 2017-01-18 CYTARABINE 02 N 220026644 CYTARABINE
220004717 220001873 1.66 null Palliative (P) 2016-03-27 2016-04-03 Cytarabine Low Dose 2 N 220026649 CYTARABINE
220004718 220001873 1.63 null Disease modification (D) 2013-11-03 2013-11-15 CYTARABINE N N 220026649 CYTARABINE
220004719 220001874 1.52 75 Curative (C) 2014-07-05 2014-07-10 AML17 TRIAL N Y 220026651 AML17 TRIAL
220004720 220001874 1.5 null Palliative (P) 2016-11-19 2016-11-26 Cytarabine Low Dose 02 null 220026651 CYTARABINE
220004721 220015847 1.78 85 Curative (C) 2013-12-13 2013-12-13 AML17 TRIAL Y N 220026663 AML17 TRIAL
220004722 220015847 null 45 Curative (C) 2017-02-04 2017-02-04 Cytarabine Low Dose N N 220026663 CYTARABINE
220004723 220015847 1.79 59.8 Not known (9) 2016-02-11 2016-02-11 Trial Unspecified Y N 220026663 TRIAL
220004724 220015847 1.67 69 Curative (C) 2016-03-19 2016-03-22 Trial Unspecified Y N 220026663 TRIAL
220004725 220015847 1.81 65.5 Disease modification (D) 2016-05-07 2016-05-10 Cytarabine low (10to20mg/m2) IV/SC 02 N 220026663 CYTARABINE
220004726 220015847 1.68 null Palliative (P) 2019-03-02 2019-03-02 Cytarabine Low Dose N N 220026663 CYTARABINE
220004727 220022151 1.79 94 Curative (C) 2014-12-08 2014-12-08 Trial Unspecified 1 null 220026676 TRIAL
220004728 220022151 1.73 100 Palliative (P) 2013-07-17 2013-07-28 Cytarabine low (10to20mg/m2) IV/SC N N 220026676 CYTARABINE
220004729 220022151 1.83 null Curative (C) 2014-11-21 2014-11-21 AML17 TRIAL N N 220026676 AML17 TRIAL
220004730 220022317 1.66 70 Palliative (P) 2016-03-22 2016-03-22 Trial Unspecified 1 N 220026681 TRIAL
220004731 220001875 1.5 null Curative (C) 2013-04-24 2013-04-24 Trial Unspecified 1 N 220026683 TRIAL
220004732 220010960 1.6 56.5 null 2017-11-09 2017-11-16 AML17 TRIAL 02 null 220026684 AML17 TRIAL
220004733 220010960 null 42 Curative (C) 2015-10-10 2015-10-11 AML17 TRIAL 1 null 220026684 AML17 TRIAL
220004734 220001876 0 39.5 Palliative (P) 2013-06-03 2013-06-03 Cytarabine Low Dose 02 N 220026687 CYTARABINE